0001317757-11-000025.txt : 20110812 0001317757-11-000025.hdr.sgml : 20110812 20110812085336 ACCESSION NUMBER: 0001317757-11-000025 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20110811 FILED AS OF DATE: 20110812 DATE AS OF CHANGE: 20110812 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ALLEN LEE F MD PhD CENTRAL INDEX KEY: 0001408474 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-10865 FILM NUMBER: 111029266 MAIL ADDRESS: STREET 1: C/O AMAG PHARMACEUTICALS, INC. STREET 2: 125 CAMBRIDGEPARK DRIVE, 6TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02140 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AMAG PHARMACEUTICALS INC. CENTRAL INDEX KEY: 0000792977 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 042742593 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 HAYDEN AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 6174983300 MAIL ADDRESS: STREET 1: 100 HAYDEN AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 FORMER COMPANY: FORMER CONFORMED NAME: ADVANCED MAGNETICS INC DATE OF NAME CHANGE: 19920703 4 1 primary_doc.xml PRIMARY DOCUMENT X0304 4 2011-08-11 0 0000792977 AMAG PHARMACEUTICALS INC. AMAG 0001408474 ALLEN LEE F MD PhD C/O AMAG PHARMACEUTICALS, INC. 100 HAYDEN AVENUE LEXINGTON MA 02421 0 1 0 0 Chief Medical Officer and EVP Common Stock 2011-08-11 4 C 0 1250 A 4523 D Common Stock 2011-08-11 4 C 0 5000 A 9523 D Common Stock 2011-08-11 4 S 0 1959 15.04 D 7564 D Restricted Stock Unit 2011-08-11 4 C 0 1250 A Common Stock 1250 1250 D Restricted Stock Unit 2011-08-11 4 C 0 5000 A Common Stock 5000 6250 D The shares were acquired by the reporting person as a result of the partial vesting of a restricted stock unit grant described below. Not applicable. The restricted stock units were scheduled to vest on August 6 and August 5, 2011, respectively. However, due to Company's black out policies and certain tax laws, both installments vested on August 11, 2011. Each restricted stock unit represents a contingent right to receive one share of common stock. Grant of restricted stock unit pursuant to the AMAG Pharmaceuticals, Inc. Amended and Restated 2000 Stock Plan. The grant vested in four equal, annual installments commencing August 8, 2008. Grant of restricted stock unit pursuant to the AMAG Pharmaceuticals, Inc. Second Amended and Restated 2007 Equity Incentive Plan. This grant vests as follows: 50% on August 5, 2010, 25% on August 5, 2011 and the remaining 25% on August 5, 2012. Joseph L. Farmer, attorney-in-fact 2011-08-12